Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Biomed Research International
|
June 3, 2014
The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation
V Cervelli, S Garcovich, A Bielli, et al.
Cancer Gene Therapy
|
November 10, 2007
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice
C Curcio, A S Khan, A Amici, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 20, 2002
Indication of hysteroscopy in tamoxifen treated breast cancer patients
F Taponeco, C Curcio, A Fasciani, et al.
International Journal of Immunopathology and Pharmacology
|
October 8, 2011
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice
Manuela Iezzi, E Quaglino, P Cappello, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 1994
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI)
C Gridelli, M D'Aprile, C Curcio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1995
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer
C Gridelli, F Perrone, M D'Aprile, et al.
American Journal of Clinical Oncology
|
December 1, 1996
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer
C Gridelli, M D'Aprile, S Palmeri, et al.
American Journal of Clinical Oncology
|
April 1, 1994
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer
C Gridelli, G P Ianniello, A Maiorino, et al.
The Journal of Biological Chemistry
|
June 27, 2001
The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line
C Curcio, M M Baqui, D Salvatore, et al.
American Journal of Medical Genetics
|
December 4, 1995
DMD and BMD in the same family due to distinct mutations
L Morandi, M Mora, S Tedeschi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Biomed Research International
|
June 3, 2014
The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation
V Cervelli, S Garcovich, A Bielli, et al.
Cancer Gene Therapy
|
November 10, 2007
DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice
C Curcio, A S Khan, A Amici, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 20, 2002
Indication of hysteroscopy in tamoxifen treated breast cancer patients
F Taponeco, C Curcio, A Fasciani, et al.
International Journal of Immunopathology and Pharmacology
|
October 8, 2011
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice
Manuela Iezzi, E Quaglino, P Cappello, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 1, 1994
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI)
C Gridelli, M D'Aprile, C Curcio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 1, 1995
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer
C Gridelli, F Perrone, M D'Aprile, et al.
American Journal of Clinical Oncology
|
December 1, 1996
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer
C Gridelli, M D'Aprile, S Palmeri, et al.
American Journal of Clinical Oncology
|
April 1, 1994
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer
C Gridelli, G P Ianniello, A Maiorino, et al.
The Journal of Biological Chemistry
|
June 27, 2001
The human type 2 iodothyronine deiodinase is a selenoprotein highly expressed in a mesothelioma cell line
C Curcio, M M Baqui, D Salvatore, et al.
American Journal of Medical Genetics
|
December 4, 1995
DMD and BMD in the same family due to distinct mutations
L Morandi, M Mora, S Tedeschi, et al.
Page
of 4